Discover 622 paid clinical trials in Arkansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Arkansas offers a variety of research opportunities for both healthy volunteers interested in paid clinical studies and individuals seeking trials for specific health conditions. Major research centers in Little Rock, Fayetteville, and Fort Smith are actively recruiting participants, providing access to advanced treatments and innovative medical care.
Filter
1
Filter results
Results: 622
Active & Responsive
Safety of MOON101 for the Treatment of Peanut Allergy
for
Peanut Allergy
Location: Chapel Hill NC, Atlanta GA, Ann Arbor MI,
Sponsor: Moonlight Therapeutics, Inc.
Sex: All
Age: 4 - 55
Code: NCT07580898
Phase1, Recruiting
Active & Responsive
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
for
Advanced Breast Cancer, Early Breast Cancer
Location: Westbury NY, The Bronx NY, New York NY, Amsterdam NY,
Sponsor: TerSera Therapeutics LLC
Sex: Female
Age: 18 - 55
Code: NCT07310420
Phase1, Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: Stamford CT, The Bronx NY, Summit NJ, Miami FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07421167
Phase2, Recruiting
Active & Responsive
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
for
Neonatal Opioid Withdrawal Syndrome
Location: Philadelphia PA, Tampa FL, Lexington KY,
Sponsor: HELP for NOWS Consortium
Sex: All
Age: 0+
Code: NCT07278375
Recruiting
Active & Responsive
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
for
Spinal Muscular Atrophy (SMA)
Location: Boston MA, Hartford CT, Hillsborough NC, Kissimmee FL,
Sponsor: argenx
Sex: All
Age: 5 - 17
Code: NCT07287982
Phase2, Recruiting
Active & Responsive
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer